Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
Ng M, Gakidou E, Lo J, Abate YH, Abbafati C, Abbas N, et al. Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. 2025;405:813–38.
Andolfi C, Fisichella PM. Epidemiology of obesity and associated comorbidities. J Laparoendoscopic Adv Surgical Tech. 2018;28:919–24.
Dowis K, Banga S. The potential health benefits of the ketogenic diet: A narrative review. Nutrients. 2021;13:1654.
Santos HO. Intermittent fasting and fat mass: What is the clinical magnitude?. Obesities. 2022;2:1–7.
Santos HO, Lavie CJ. Weight loss and its influence on high-density lipoprotein cholesterol (HDL-C) concentrations: A noble clinical hesitation. Clin Nutr ESPEN. 2021;42:90–2.
Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015;31:1–13.
Macedo RC, Santos HO, Tinsley GM, Reischak-Oliveira A. Low-carbohydrate diets: Effects on metabolism and exercise–A comprehensive literature review. Clin Nutr ESPEN. 2020;40:17–26.
Mirza NM, Palmer MG, Sinclair KB, McCarter R, He J, Ebbeling CB, et al. Effects of a low glycemic load or a low-fat dietary intervention on body weight in obese Hispanic American children and adolescents: a randomized controlled trial. Am J Clin Nutr. 2013;97:276–85.
Lei L, Huang J, Zhang L, Hong Y, Hui S, Yang J. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors in overweight and obese adults: A meta-analysis of randomized controlled trials. Front Nutr. 2022;9:935234.
Higashi Y, Noma K, Yoshizumi M, Kihara Y. Endothelial function and oxidative stress in cardiovascular diseases. Circulation J. 2009;73:411–8.
Sandoo A, van Zanten JJV, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4:302.
Pierce GL, Beske SD, Lawson BR, Southall KL, Benay FJ, Donato AJ, et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008;52:72–9.
Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc. 2015;4:e002270.
Maruhashi T, Kajikawa M, Kishimoto S, Hashimoto H, Takaeko Y, Yamaji T, et al. Diagnostic criteria of flow-mediated vasodilation for normal endothelial function and nitroglycerin-induced vasodilation for normal vascular smooth muscle function of the brachial artery. J Am Heart Assoc. 2020;9:e013915.
Heiss C, Rodriguez-Mateos A, Bapir M, Skene SS, Sies H, Kelm M. Flow-mediated dilation reference values for evaluation of endothelial function and cardiovascular health. Cardiovascular Res. 2023;119:283–93.
Buscemi S, Verga S, Tranchina M, Cottone S, Cerasola G. Effects of hypocaloric very-low-carbohydrate diet vs. Mediterranean diet on endothelial function in obese women. Eur J Clin Investig. 2009;39:339–47.
Phillips SA, Jurva JW, Syed AQ, Syed AQ, Kulinski JP, Pleuss J, et al. Benefit of low-fat over low-carbohydrate diet on endothelial health in obesity. Hypertension. 2008;51:376–82.
Barbosa-Yañez RL, Dambeck U, Li L, Machann J, Kabisch S, Pfeiffer AF. Acute endothelial benefits of fat restriction over carbohydrate restriction in type 2 diabetes mellitus: Beyond carbs and fats. Nutrients. 2018;10:1859.
Gram-Kampmann EM, Olesen TB, Hansen CD, Hugger MB, Jensen JM, Handberg A, et al. A six-month low-carbohydrate diet high in fat does not adversely affect endothelial function or markers of low-grade inflammation in patients with type 2 diabetes: an open-label randomized controlled trial. Cardiovascular Diabetol. 2023;22:212.
Schwingshackl L, Hoffmann G. Low-carbohydrate diets impair flow-mediated dilatation: evidence from a systematic review and meta-analysis. Br J Nutr. 2013;110:969–70.
Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS Jr, et al. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176:S44–S54.
Chawla S, Tessarolo Silva F, Amaral Medeiros S, Mekary RA, Radenkovic D. The effect of low-fat and low-carbohydrate diets on weight loss and lipid levels: a systematic review and meta-analysis. Nutrients. 2020;12:3774.
Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials. Br J Nutr. 2016;115:466–79.
Apekey TA, Maynard MJ, Kittana M, Kunutsor SK. Comparison of the effectiveness of low carbohydrate versus low fat diets, in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials. Nutrients. 2022;14:4391.
Sackner-Bernstein J, Kanter D, Kaul S. Dietary intervention for overweight and obese adults: comparison of low-carbohydrate and low-fat diets. A meta-analysis. PloS one. 2015;10:e0139817.
Li S, Ding L, Xiao X. Comparing the Efficacy and Safety of Low-Carbohydrate Diets with Low-Fat Diets for Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Int J Endocrinol. 2021;2021:8521756.
Darand M, Hassanizadeh S, Talebi S, Darabi Z, Bagherniya M, Yaghoubi F, et al. Comparison of the Effect of a Low-Carbohydrate Diet with a Low-Fat Diet on Anthropometric Indices and Body Fat Percentage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr Food Security. 2023;8:493–520.
Bueno NB, de Melo ISV, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. Br J Nutr. 2013;110:1178–87.
Siddique S, Hameed Khan A, Shahab H, Zhang YQ, Chin Tay J, Buranakitjaroen P, et al. Office blood pressure measurement: a comprehensive review. J Clin Hypertension. 2021;23:440–9.
Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.
Liu J, Li Y, Ge J, Yan X, Zhang H, Zheng X, et al. Lowering systolic blood pressure to less than 120 mm Hg versus less than 140 mm Hg in patients with high cardiovascular risk with and without diabetes or previous stroke: an open-label, blinded-outcome, randomised trial. Lancet. 2024;404:245–55.
Group SR. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.
Sharif S, Van der Graaf Y, Cramer MJ, Kapelle LJ, de Borst GJ, Visseren FL, et al. Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes. Cardiovascular Diabetol. 2021;20:1–8.
Mortensen MB, Dzaye O, Bøtker HE, Jensen JM, Maeng M, Bentzon JF, et al. Low-density lipoprotein cholesterol is predominantly associated with atherosclerotic cardiovascular disease events in patients with evidence of coronary atherosclerosis: the Western Denmark Heart Registry. Circulation. 2023;147:1053–63.
Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur heart J. 2017;38:2459–72.
Peng K, Li X, Wang Z, Li M, Yang Y. Association of low-density lipoprotein cholesterol levels with the risk of mortality and cardiovascular events: A meta-analysis of cohort studies with 1,232,694 participants. Medicine. 2022;101:e32003.
Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. Eur heart J. 2021;42:4791–806.
Christensen P, Meinert Larsen T, Westerterp-Plantenga M, Macdonald I, Martinez JA, Handjiev S, et al. Men and women respond differently to rapid weight loss: Metabolic outcomes of a multi-centre intervention study after a low-energy diet in 2500 overweight, individuals with pre-diabetes (PREVIEW). Diab, Obes Metab. 2018;20:2840–51.
Shai I, Spence JD, Schwarzfuchs D, Henkin Y, Parraga G, Rudich A, et al. Dietary intervention to reverse carotid atherosclerosis. Circulation. 2010;121:1200–8.
Lari A, Sohouli MH, Fatahi S, Cerqueira HS, Santos HO, Pourrajab B, et al. The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: A systematic review and meta-analysis of randomized controlled trials. Nutr, Metab Cardiovascular Dis. 2021;31:2766–78.
Stevens VJ, Corrigan SA, Obarzanek E, Bernauer E, Cook NR, Hebert P, et al. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. Arch Intern Med. 1993;153:849–58.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–9.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:1–13.
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions, John Wiley & Sons, 2019.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:1–10.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
Keogh JB, Brinkworth GD, Noakes M, Belobrajdic DP, Buckley JD, Clifton PM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567–76. https://doi.org/10.1093/ajcn/87.3.567.
Ruth MR, Port AM, Shah M, Bourland AC, Istfan NW, Nelson KP, et al. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metab: Clin Exp. 2013;62:1779–87. https://doi.org/10.1016/j.metabol.2013.07.006.
Varady KA, Bhutani S, Klempel MC, Phillips SA. Improvements in vascular health by a low-fat diet, but not a high-fat diet, are mediated by changes in adipocyte biology. Nutr J. 2011;10. https://doi.org/10.1186/1475-2891-10-8.
Wycherley TP, Brinkworth GD, Keogh JB, Noakes M, Buckley JD, Clifton PM. Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients: Original Article. J Intern Med. 2010;267:452–61. https://doi.org/10.1111/j.1365-2796.2009.02174.x.
Keogh JB, Brinkworth GD, Clifton PM. Effects of weight loss on a low-carbohydrate diet on flow-mediated dilatation, adhesion molecules and adiponectin. Br J Nutr. 2007;98:852–9. https://doi.org/10.1017/s0007114507747815.
Volek JS, Ballard KD, Silvestre R, Judelson DA, Quann EE, Forsythe CE, et al. Effects of dietary carbohydrate restriction versus low-fat diet on flow-mediated dilation. Metabolism. 2009;58:1769–77. https://doi.org/10.1016/j.metabol.2009.06.005. e-pub ahead of print 20090725.
Wycherley TP, Thompson CH, Buckley JD, Luscombe-Marsh ND, Noakes M, Wittert GA, et al. Long-term effects of weight loss with a very-low carbohydrate, low saturated fat diet on flow mediated dilatation in patients with type 2 diabetes: A randomised controlled trial. Atherosclerosis. 2016;252:28–31. https://doi.org/10.1016/j.atherosclerosis.2016.07.908.
Inaba Y, Chen JA, Bergmann SR. Prediction of future cardiovascular outcomes by flow-mediated vasodilatation of brachial artery: a meta-analysis. Int J cardiovascular imaging. 2010;26:631–40.
Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133:187–225.
Govers E. Medical Nutritional Therapy Laid in Expert Hands to Strongly Suppress Insulin Resistance and to Restore Metabolic Health; a Review of the Evidence. EC Nutr. 2021;16:06–19.
Keogh JB, Grieger JA, Noakes M, Clifton PM. Flow-mediated dilatation is impaired by a high–saturated fat diet but not by a high-carbohydrate diet. Arteriosclerosis, thrombosis, Vasc Biol. 2005;25:1274–9.
De Roos N, Siebelink E, Bots M, Van Tol A, Schouten E, Katan M. Trans monounsaturated fatty acids and saturated fatty acids have similar effects on postprandial flow-mediated vasodilation. Eur J Clin Nutr. 2002;56:674–9.
Ong PJ, Dean TS, Hayward CS, Della Monica PL, Sanders TA, Collins P. Effect of fat and carbohydrate consumption on endothelial function. Lancet. 1999;354:2134.
Cortés B, Núñez I, Cofán M, Gilabert R, Pérez-Heras A, Casals E, et al. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol. 2006;48:1666–71.
Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378:e34.
Ruggiero E, Di Castelnuovo A, Costanzo S, Esposito S, De Curtis A, Persichillo M, et al. Olive oil consumption is associated with lower cancer, cardiovascular and all-cause mortality among Italian adults: prospective results from the Moli-sani Study and analysis of potential biological mechanisms. Eur J Clin Nutr. 2024: 1-10.
Skulas-Ray AC, Wilson PW, Harris WS, Brinton EA, Kris-Etherton PM, Richter CK, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019;140:e673–91.
Li Z, Wong A, Henning SM, Zhang Y, Jones A, Zerlin A, et al. Hass avocado modulates postprandial vascular reactivity and postprandial inflammatory responses to a hamburger meal in healthy volunteers. Food Funct. 2013;4:384–91.
Davis KM, Petersen KS, Matthan NR, Legro RS, Kris-Etherton PM. Effect of Incorporating 1 Avocado per Day Versus Habitual Diet on Vascular Function in Adults With Abdominal Obesity: An Ancillary Study of HAT, a Randomized Controlled Trial. J Am Heart Assoc. 2024;13:e030497.
Birk G, Dawson E, Batterham A, Atkinson G, Cable T, Thijssen D, et al. Effects of exercise intensity on flow mediated dilation in healthy humans. Int J sports Med. 2013;34:409–14.
Hwang I-C, Kim K-H, Choi W-S, Kim H-J, Im M-S, Kim Y-J, et al. Impact of acute exercise on brachial artery flow-mediated dilatation in young healthy people. Cardiovascular ultrasound. 2012;10:1–12.
Kokkinos P, Faselis C, Samuel IBH, Pittaras A, Doumas M, Murphy R, et al. Cardiorespiratory fitness and mortality risk across the spectra of age, race, and sex. J Am Coll Cardiol. 2022;80:598–609.
Shan Z, Guo Y, Hu FB, Liu L, Qi Q. Association of low-carbohydrate and low-fat diets with mortality among US adults. JAMA Intern Med. 2020;180:513–23.
Seidelmann SB, Claggett B, Cheng S, Henglin M, Shah A, Steffen LM, et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018;3:e419–28.
Paoli A, Rubini A, Volek J, Grimaldi K. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67:789–96.
Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS, Brehm BJ, et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285–93.
Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41:bnaa004.
Foley PJ. Effect of low carbohydrate diets on insulin resistance and the metabolic syndrome. Curr Opin Endocrinol, Diab Obes. 2021;28:463–8.
Superko HR, Pendyala L, Williams PT, Momary KM, King III, SB, et al. High-density lipoprotein subclasses and their relationship to cardiovascular disease. J Clin Lipido. 2012;6:496–523.
Santos HO, Earnest CP, Tinsley GM, Izidoro LF, Macedo RC. Small dense low-density lipoprotein-cholesterol (sdLDL-C): analysis, effects on cardiovascular endpoints and dietary strategies. Prog cardiovascular Dis. 2020;63:503–9.
Hyde PN, Sapper TN, Crabtree CD, LaFountain RA, Bowling ML, Buga A, et al. Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI insight 2019;4.
Luciani L, Pedrelli M, Parini P. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes. Atherosclerosis. 2024;394:117545.
Frimel TN, Sinacore DR, Villareal DT. Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci sports Exerc. 2008;40:1213.
Weinheimer EM, Sands LP, Campbell WW. A systematic review of the separate and combined effects of energy restriction and exercise on fat-free mass in middle-aged and older adults: implications for sarcopenic obesity. Nutr Rev. 2010;68:375–88.
Phillips SM. A brief review of higher dietary protein diets in weight loss: a focus on athletes. Sports Med. 2014;44:149–53.
Helms ER, Zinn C, Rowlands DS, Brown SR. A systematic review of dietary protein during caloric restriction in resistance trained lean athletes: a case for higher intakes. Int J sport Nutr Exerc Metab. 2014;24:127–38.
Longland TM, Oikawa SY, Mitchell CJ, Devries MC, Phillips SM. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss: a randomized trial. Am J Clin Nutr. 2016;103:738–46.
Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 2016;68:324–33.
Filippini T, Malavolti M, Whelton PK, Naska A, Orsini N, Vinceti M. Blood pressure effects of sodium reduction: dose–response meta-analysis of experimental studies. Circulation. 2021;143:1542–67.
Ashor AW, Brown R, Keenan PD, Willis ND, Siervo M, Mathers JC. Limited evidence for a beneficial effect of vitamin C supplementation on biomarkers of cardiovascular diseases: An umbrella review of systematic reviews and meta-analyses. Nutr Res. 2019;61:1–12.
Kim C, Park K. Dietary niacin intake and risk of dyslipidemia: a pooled analysis of three prospective cohort studies. Clin Nutr. 2022;41:2749–58.
Radkhah N, Zarezadeh M, Jamilian P, Ostadrahimi A. The effect of vitamin D supplementation on lipid profiles: an umbrella review of meta-analyses. Adv Nutr. 2023;14:1479–98.
Santos HO, Martins CEC, Forbes SC, Delpino FM. A scoping review of vitamin D for nonskeletal health: a framework for evidence-based clinical practice. Clin Therapeutics. 2023;45:e127–50.
Hariri E, Kassis N, Iskandar J-P, Schurgers LJ, Saad A, Abdelfattah O, et al. Vitamin K2—a neglected player in cardiovascular health: a narrative review. Open Heart. 2021;8:e001715.
Santos HO, Macedo RC. Cocoa-induced (Theobroma cacao) effects on cardiovascular system: HDL modulation pathways. Clin Nutr ESPEN. 2018;27:10–15.
Wang X, Ma H, Sun Q, Li J, Heianza Y, Van Dam RM, et al. Coffee drinking timing and mortality in US adults. Eur Heart J. 2025;46:749–59.
Haghighatdoost F, Hajihashemi P, de Sousa Romeiro AM, Mohammadifard N, Sarrafzadegan N, de Oliveira C, et al. Coffee consumption and risk of hypertension in adults: systematic review and meta-analysis. Nutrients. 2023;15:3060.
Chung M, Zhao N, Wang D, Shams-White M, Karlsen M, Cassidy A, et al. Dose–response relation between tea consumption and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of population-based studies. Adv Nutr. 2020;11:790–814.
Delpino FM, Dos Santos FS, Flores TR, Cerqueira HS, Santos HO. The effects of blueberry and cranberry supplementation on blood pressure in patients with cardiovascular diseases: A systematic review and meta-analysis of randomized clinical trials. Phytother Res. 2024;38:646–61.
Santos HO, Genario R, Gomes GK, Schoenfeld BJ. Cherry intake as a dietary strategy in sport and diseases: a review of clinical applicability and mechanisms of action. Crit Rev Food Sci Nutr. 2021;61:417–30.
Martínez-González MA, Sayón-Orea C, Bullón-Vela V, Bes-Rastrollo M, Rodríguez-Artalejo F, Yusta-Boyo MJ, et al. Effect of olive oil consumption on cardiovascular disease, cancer, type 2 diabetes, and all-cause mortality: A systematic review and meta-analysis. Clin Nutr. 2022;41:2659–82.
Li J, Jiang B, O. Santos H, Santos D, Singh A, Wang L. Effects of walnut intake on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2020;34:2921–31.
Lichtenstein AH, Kris-Etherton PM, Petersen KS, Matthan NR, Barnes S, Vitolins MZ, et al. Effect of incorporating 1 avocado per day versus habitual diet on visceral adiposity: a randomized trial. J Am Heart Assoc. 2022;11:e025657.
MT Streppel, Arends LR, van’t Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150–6.
Whelton SP, Hyre AD, Pedersen B, Yi Y, Whelton PK, He J. Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials. In: LWW, 2005. pp 475-81.
Ghavami A, Banpouri S, Ziaei R, Talebi S, Vajdi M, Nattagh-Eshtivani E, et al. Effect of soluble fiber on blood pressure in adults: a systematic review and dose–response meta-analysis of randomized controlled trials. Nutr J. 2023;22:51.
Gibb RD, Sloan KJ, McRorie JW Jr. Psyllium is a natural nonfermented gel-forming fiber that is effective for weight loss: A comprehensive review and meta-analysis. J Am Assoc Nurse Practitioners. 2023;35:468–76.
Jovanovski E, Yashpal S, Komishon A, Zurbau A, Mejia SB, Ho HVT, et al. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2018;108:922–32.
Lin J, Sun Y, Santos HO, Găman M-A, Bhat LT, Cui Y. Effects of guar gum supplementation on the lipid profile: A systematic review and meta-analysis of randomized controlled trials. Nutr, Metab Cardiovascular Dis. 2021;31:3271–81.
Santos HO, Bueno AA, Mota JF. The effect of artichoke on lipid profile: A review of possible mechanisms of action. Pharmacol Res. 2018;137:170–8.
Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JP, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diab Endocrinol. 2025;13:221–62.
Jin X, Qiu T, Li L, Yu R, Chen X, Li C, et al. Pathophysiology of obesity and its associated diseases. Acta Pharmaceutica Sin B. 2023;13:2403–24.
Corona G, Vignozzi L, Sforza A, Mannucci E, Maggi M. Obesity and late-onset hypogonadism. Mol Cell Endocrinol. 2015;418:120–33.
Alexander L, Christensen SM, Richardson L, Ingersoll AB, Burridge K, Golden A, et al. Nutrition and physical activity: an obesity medicine association (OMA) clinical practice statement 2022. Obes Pillars. 2022;1:100005.
Bays HE, Fitch A, Christensen S, Burridge K, Tondt J. Anti-obesity medications and investigational agents: an obesity medicine association (OMA) clinical practice statement (CPS) 2022. Obes Pillars. 2022;2:100018.
Sarma S, Palcu P. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: a systematic review and meta-analysis. Obesity. 2022;30:2111–21.
Barrea L, Verde L, Schiavo L, Sarno G, Camajani E, Iannelli A, et al. Very low-calorie ketogenic diet (VLCKD) as pre-operative first-line dietary therapy in patients with obesity who are candidates for bariatric surgery. Nutrients. 2023;15:1907.
Colangeli L, Gentileschi P, Sbraccia P, Guglielmi V. Ketogenic diet for preoperative weight reduction in bariatric surgery: A narrative review. Nutrients. 2022;14:3610.
Erdem NZ, Ozelgun D, Taskin HE, Avsar FM. Comparison of a pre-bariatric surgery very low-calorie ketogenic diet and the Mediterranean diet effects on weight loss, metabolic parameters, and liver size reduction. Sci Rep. 2022;12:20686.
Albanese A, Prevedello L, Markovich M, Busetto L, Vettor R, Foletto M. Pre-operative very low calorie ketogenic diet (VLCKD) vs. very low calorie diet (VLCD): surgical impact. Obes Surg. 2019;29:292–6.
Santella B, Mingo M, Papp A, Rice M, Chiappetta S, Calabrese P, et al. Safety and Effectiveness of a 4-Week Diet on Low-Carb Ready-to-Eat Ketogenic Products as Preoperative Care Treatment in Patients Scheduled for Metabolic and Bariatric Surgery. Nutrients. 2024;16:3875.
Correa LL, Moretti A, de Sousa PAM, Dinis L, de Souza MF, Tostes I, et al. Effectiveness and safety of a very low-calorie ketogenic diet on weight regain following bariatric surgery. Obes Surg. 2021;31:5383–90.
Swenson BR, Schulman AS, Edwards MJ, Gross MP, Hedrick TL, Weltman AL, et al. The effect of a low-carbohydrate, high-protein diet on post laparoscopic gastric bypass weight loss: a prospective randomized trial. J Surgical Res. 2007;142:308–13.
Murakami M, Tognini P. Molecular mechanisms underlying the bioactive properties of a ketogenic diet. Nutrients. 2022;14:782.
Saleh SA, Santos HO, Găman M-A, Cerqueira HS, Zaher EA, Alromaih WR, et al. Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2024;59:70–80.
Khodami B, Hatami B, Yari Z, Alavian SM, Sadeghi A, Varkaneh HK, et al. Effects of a low free sugar diet on the management of nonalcoholic fatty liver disease: a randomized clinical trial. Eur J Clin Nutr. 2022;76:987–94.
Veum VL, Laupsa-Borge J, Eng Ø, Rostrup E, Larsen TH, Nordrehaug JE, et al. Visceral adiposity and metabolic syndrome after very high–fat and low-fat isocaloric diets: A randomized controlled trial. Am J Clin Nutr. 2017;105:85–99.
Haufe S, Engeli S, Kast P, Böhnke J, Utz W, Haas V, et al. Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology. 2011;53:1504–14.
Martins C, Bryan DR, Sweatt SK, Garvey WT, Fontaine KR, Dutton GR, et al. The impact of a low-carbohydrate (vs. low-fat) diet on fat mass loss in African American women is modulated by insulin sensitivity. Obesity. 2025;33:257–66.
Zhang X, Zheng Y, Guo Y, Lai Z. The effect of low carbohydrate diet on polycystic ovary syndrome: A meta-analysis of randomized controlled trials. Int J Endocrinol. 2019;2019:4386401.
Gower BA, Chandler-Laney PC, Ovalle F, Goree LL, Azziz R, Desmond RA, et al. Favourable metabolic effects of a eucaloric lower-carbohydrate diet in women with PCOS. Clin Endocrinol. 2013;79:550–7.
Lundanes J, Sandnes F, Gjeilo KH, Hansson P, Salater S, Martins C, et al. Effect of a low-carbohydrate diet on pain and quality of life in female patients with lipedema: a randomized controlled trial. Obesity. 2024;32:1071–82.
Lundanes J, Gårseth M, Taylor S, Crescenzi R, Pridmore M, Wagnild R, et al. The effect of a low-carbohydrate diet on subcutaneous adipose tissue in females with lipedema. Front Nutr. 2024;11:1484612.
Lundanes J, Nes VF, Aakervik O, Ryan L, Hansson P, Rokstad AM, et al. Changes in cytokines and fibrotic growth factors after low-carbohydrate or low-fat low-energy diets in females with lipedema. Curr Develop Nutr. 2025;9:104571.
